MKTXS appoints Dr Steven Bradshaw as director
July 30, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Global healthcare strategy firm MKTXS has appointed British medical research expert Dr Steven Bradshaw as its new European director. Market …
AstraZeneca secures respiratory drugs from Almirall
July 30, 2014Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs
AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …
Amgen to wield axe on 2,900 jobs
July 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts
Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …
Pfizer revenue drops, but new cancer drugs shine
July 29, 2014Research and Development, Sales and Marketing Cancer, Inlyta. axitinib, Lipitor, Lyrica, Pfizer, Q2, Sutent, viagra
Pfizer saw a 2% drop in sales for the second quarter but has pointed to the stellar growth of its …
Copycat Lipitor helps toward £1.3bn NHS savings
July 29, 2014Research and Development, Sales and Marketing ABPI, Lipitor, NHS, Teva, prescribing PPRS, vba
In 2013 generic usage increased to more than three-quarters of all NHS prescriptions according to new data released by the …
Roche’s blood cancer drug gains EU approval
July 29, 2014Research and Development, Sales and Marketing CLL, Cancer, Gilead, Janssen, Roche
The European Commission has approved Roche’s new leukaemia drug Gazyvaro (obinutuzumab) as competition for the blood cancer market heats up. …
Healthcare marketer Renée Mellas re-joins Area 23 as MD
July 29, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FCS Health
Healthcare and pharma marketing professional Renée Mellas has returned to Area 23, an FCB Health company, as executive vice president …
US doctor infected with Ebola as disease spreads
July 28, 2014Medical Communications, Sales and Marketing Ebola, WHO
An American doctor working with Ebola patients in Liberia has been infected with the virus as health officials struggle to …
Google hopes DNA search will yield health results
July 27, 2014Medical Communications, Research and Development, Sales and Marketing DNA, calico, google, smart lens
Google is to collect samples of human tissue from thousands of people as part of an experiment that could help …
Europe warned over cancer research risk
July 27, 2014Medical Communications, Research and Development, Sales and Marketing ESMO, EU, Macmillan, data
A leading European doctors’ group is warning that new data protection rules could make cancer research ‘impossible’ whilst also adding …
EMA approvals for rival blood cancer drugs
July 27, 2014Research and Development, Sales and Marketing CLL, Gilead, Janssen, chronic lymphocytic leukaemia, imbruvica, zydelig
Gilead and Janssen are set to face off in Europe after the CHMP recommended both of their rival blood cancer …
NHS England’s Sovaldi fund: opening the floodgates?
July 26, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDG, NICE, Professor David Haslam, hep C, sovaldi
Whilst seemingly more and more barriers are being erected to slow down the adoption of new medicines, there is a …
GSK seeks regulatory review of first malaria vaccine
July 26, 2014Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, malaria, rts, s
GSK has submitted a regulatory application to the European Medicines Agency for its malaria vaccine candidate RTS,S and hopes it …
More action needed on antibiotic resistance
July 25, 2014Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh
Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …
New director for Quest Diagnostics
July 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing quest diagnostics, vicky gregg
Diagnostic information services firm Quest Diagnostics has confirmed that Vicky Gregg is to serve as a director on its board. Gregg …
NICE extends recommendation for Efient
July 24, 2014Sales and Marketing ACS, Efient, NICE, Plavix, longs ton, prasugrel
In updated guidance NICE has extended its recommendation of Efient (prasugrel) in combination with aspirin for preventing blood clots in …
FDA approves Gilead’s blood cancer drug
July 24, 2014Research and Development, Sales and Marketing Cancer, FDA, Gilead, blood, follicular lymphoma and small lymphocytic lymphoma, lymphocytic leukaemia, sovaldi, zydelig
The Food and Drug Administration has approved Gilead Sciences new treatment Zydelig (idelalisib) to treat three types of blood cancer. …
New president for Mental Health Foundation
July 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Dinesh Bhugra, Mental Health Foundation
Dr Dinesh Bhugra who has served as chair of the Mental Health Foundation for three years has been appointed as …
BMJ investigation raises new concerns over Pradaxa
July 24, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, Boehringer, Channel 4, Pradaxa, blood, warfarin
An investigation by The BMJ has raised fresh concerns about Boehringer’s top-selling blood thinner Pradaxa (dabigatran) and the regulatory decisions …
Another major drop in sales for GSK
July 23, 2014Sales and Marketing China, GSK, Q2, Witty, bribery, sales, scandal, sex
GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
